Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs WePeptideRx

By GLP-1 ScorecardUpdated

Eden
Site position #16

Higher score

WePeptideRxFactor scores not reassessed.
Site position #321

Lower score

Score comparison

Eden has the higher recorded score — 81.6/100 to 61.4/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Before you choose

Before comparing the headline prices, the Eden review and the WePeptideRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, 9amHealth vs Eden and EdgeRx vs WePeptideRx compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEden +37
85
48
Dose & formulationEden +22
86
64
Clinical oversightWePeptideRx +26
55
81
Labs & monitoringEden +39
92
53
FulfillmentEden +26
93
67
Contract termsEden +35
90
55
Eden · top barWePeptideRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenWePeptideRx
WeighScore81.6/10061.4/100
GradeB−C
Site position#16#321
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkoutFrom $149 per 30-day supply (advertised discount, compounded)
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkoutFrom $159 per 30-day supply (advertised discount, compounded)
CoverageAll 50 statesCoverage varies by treatment and state
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
WePeptideRx

Site position #321 · C

Factor scores not reassessed.

Strengths

  • Lists compounded and brand-name treatment options
  • Advertises consultation and shipping in the treatment price
  • Publishes a refund process for clinically declined items

What to consider

  • Charges at checkout before clinical review
  • The public discount does not establish the next bill
  • Medication refunds are unavailable after dispensing and shipping

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard